Company research
ACCENDRA HEALTH INC/VA/
CIK 75252Updated Nov 20, 2026
Historical securities (1)
ACH · NYSE · equity · closed Oct 22, 2026ACCH price & chart
Loading TradingView…
OTC:ACCH on TradingView ↗About the company
Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology and ostomy, visit www.accendrahealth.com.
In the news
No coverage from other publishers is available.
Recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Show 5 more recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
DEF 14A filing
PRE 14A filing
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
SCHEDULE 13G - filed by BANK OF AMERICA CORP /DE/ regarding ACCENDRA HEALTH INC/VA/
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 4,036,226,000Source | 5,081,282,000Source | 2,107,412,000Source | 4,154,545,000Source | 5,304,004,000Source | 2,415,982,000Source | 4,856,424,000Source | 5,207,993,000Source | 2,451,761,000Source | 4,656,156,000Source | 5,093,322,000Source | 5,386,283,000Source |
| Property, Plant and Equipment, NetUSD | 259,729,000Source | — | 208,666,000Source | 259,301,000Source | — | 227,732,000Source | — | — | 256,161,000Source | — | — | — |
| GoodwillUSD | 1,228,140,000Source | 1,642,196,000Source | 1,228,140,000Source | 1,228,140,000Source | 1,634,723,000Source | 1,228,140,000Source | 1,331,931,000Source | 1,635,368,000Source | 1,228,140,000Source | 1,331,281,000Source | 1,638,846,000Source | 1,636,705,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 165,694,000Source | 313,284,000Source | 78,007,000Source | 194,924,000Source | 326,173,000Source | 107,236,000Source | 285,086,000Source | 342,593,000Source | 136,465,000Source | 298,726,000Source | 361,835,000Source | 445,042,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 32,837,000Source | 45,454,000Source | 7,651,000Source | 38,258,000Source | 243,671,000Source | 336,880,000Source | 59,436,000Source | 244,866,000Source | 281,989,000Source | 49,382,000Source | 243,037,000Source | 69,467,000Source |
| Inventory, NetUSD | 63,847,000Source | 1,242,453,000Source | 73,345,000Source | 69,227,000Source | 1,231,413,000Source | 65,285,000Source | 1,408,539,000Source | 1,144,597,000Source | 74,435,000Source | 1,131,879,000Source | 1,110,606,000Source | 1,333,585,000Source |
| Assets, CurrentUSD | 2,131,673,000Source | 2,116,538,000Source | 271,449,000Source | 2,298,513,000Source | 2,327,070,000Source | 588,500,000Source | 2,206,198,000Source | 2,236,344,000Source | 547,871,000Source | 2,021,017,000Source | 2,102,790,000Source | 2,295,185,000Source |
| Operating Lease, Right-of-Use AssetUSD | 119,093,000Source | 357,264,000Source | 97,008,000Source | 120,188,000Source | 368,471,000Source | 101,967,000Source | 383,111,000Source | 349,984,000Source | 109,099,000Source | 355,627,000Source | 296,533,000Source | 280,665,000Source |
| Other Assets, NoncurrentUSD | 131,897,000Source | 153,254,000Source | 224,142,000Source | 53,479,000Source | 154,492,000Source | 162,407,000Source | 129,766,000Source | 142,319,000Source | 174,025,000Source | 140,158,000Source | 149,346,000Source | 150,417,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 4,465,733,000Source | 4,206,690,000Source | 2,658,350,000Source | 4,435,555,000Source | 4,443,302,000Source | 2,880,747,000Source | 4,285,445,000Source | 4,313,125,000Source | 2,912,739,000Source | 4,090,930,000Source | 4,169,156,000Source | 4,440,679,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 154,598,000Source | 154,123,000Source | 153,809,000Source | 154,393,000Source | 154,096,000Source | 153,167,000Source | 154,439,000Source | 152,897,000Source | 152,777,000Source | 154,398,000Source | 153,092,000Source | 152,557,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,022,161,000Source | 302,138,000Source | -1,175,290,000Source | -871,885,000Source | 314,908,000Source | -1,086,220,000Source | 1,020,000Source | 346,821,000Source | -1,079,752,000Source | 6,021,000Source | 368,707,000Source | 410,008,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -30,413,000Source | -27,418,000Source | -1,051,000Source | -30,219,000Source | -48,744,000Source | -798,000Source | -44,211,000Source | -43,437,000Source | -885,000Source | -49,344,000Source | -31,818,000Source | -35,855,000Source |
| Stockholders' Equity Attributable to ParentUSD | -429,507,000Source | 895,730,000Source | -550,938,000Source | -281,010,000Source | 881,840,000Source | -464,765,000Source | 570,979,000Source | 916,006,000Source | -460,978,000Source | 565,226,000Source | 924,166,000Source | 945,604,000Source |
| Additional Paid in Capital, Common StockUSD | 468,469,000Source | 445,749,000Source | 471,594,000Source | 466,701,000Source | 440,442,000Source | 469,086,000Source | 459,731,000Source | 438,587,000Source | 466,882,000Source | 454,151,000Source | 434,185,000Source | 418,894,000Source |
| Liabilities and EquityUSD | 4,036,226,000Source | 5,081,282,000Source | 2,107,412,000Source | 4,154,545,000Source | 5,304,004,000Source | 2,415,982,000Source | 4,856,424,000Source | 5,207,993,000Source | 2,451,761,000Source | 4,656,156,000Source | 5,093,322,000Source | 5,386,283,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 2,465,967,000Source | 1,934,166,000Source | 666,216,000Source | 2,674,523,000Source | 2,131,185,000Source | 1,203,104,000Source | 1,960,215,000Source | 1,933,091,000Source | 947,075,000Source | 1,873,739,000Source | 1,891,885,000Source | 1,566,466,000Source |
| Operating Lease, Liability, CurrentUSD | 46,031,000Source | — | 38,397,000Source | 43,704,000Source | — | — | — | — | 43,272,000Source | 91,221,000Source | 85,665,000Source | 76,805,000Source |
| Accounts Payable, CurrentUSD | 339,728,000Source | 1,338,021,000Source | 352,798,000Source | 357,037,000Source | 1,381,871,000Source | 374,824,000Source | 1,380,736,000Source | 1,218,817,000Source | 363,565,000Source | 1,251,964,000Source | 1,171,882,000Source | 1,147,414,000Source |
| Operating Lease, Liability, NoncurrentUSD | 81,352,000Source | 288,043,000Source | 63,235,000Source | 80,982,000Source | 297,728,000Source | 67,466,000Source | 324,032,000Source | 276,327,000Source | 70,317,000Source | 286,212,000Source | 222,429,000Source | 215,469,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 25,650,000Source | — | 345,000Source | 28,900,000Source | — | 16,307,000Source | 34,437,000Source | — | 22,456,000Source | 41,652,000Source | 60,833,000Source |
| Other Liabilities, NoncurrentUSD | 83,153,000Source | 116,483,000Source | 210,836,000Source | 84,960,000Source | 113,689,000Source | 88,236,000Source | 87,376,000Source | 123,265,000Source | 95,471,000Source | 100,476,000Source | 122,592,000Source | 114,943,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | 1,316,000Source | 26,679,000Source | 51,184,000Source |
| Long-term Debt, Current MaturitiesUSD | 280,000,000Source | 42,626,000Source | 0Source | 383,000,000Source | 210,913,000Source | 581,250,000Source | 49,947,000Source | 207,658,000Source | 250,000,000Source | 45,549,000Source | 206,904,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -6,468,000Source | -24,982,000Source | -1,100,642,000Source | — | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 61,742,000Source | 42,902,000Source | 214,524,000Source | 264,775,000Source | 287,377,000Source | 228,667,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,090,000Source | 4,421,000Source | 12,873,000Source | 26,836,000Source | 23,218,000Source | 20,993,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -9,150,000Source | 6,319,000Source | 6,854,000Source | 26,228,000Source | -224,338,000Source | -166,559,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -17,887,000Source | -26,115,000Source | -23,733,000Source | -26,361,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | -35,066,000Source | — | 161,495,000Source | 740,710,000Source | 325,006,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | 55,697,000Source | 18,091,000Source | — | 0Source | 1,684,607,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 53,925,000Source | -48,200,000Source | 144,423,000Source | -116,533,000Source | -137,254,000Source | -1,804,476,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | 0Source | 410,000Source | 1,910,000Source | -8,203,000Source | 936,000Source | 1,670,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 41,646,000Source | 45,793,000Source | 190,956,000Source | 210,865,000Source | 190,870,000Source | 158,090,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 1,503,000Source | 10,179,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 51,084,000Source | 92,778,000Source | 188,078,000Source | -267,603,000Source | -417,330,000Source | 1,497,105,000Source |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | —Source | —Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -416,000Source | -146,000Source | -3,116,000Source | -23,406,000Source | -637,000Source | -42,793,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | 0Source | — | 244,197,000Source | 320,693,000Source | 4,500,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 54,891,000Source | 10,054,000Source | 232,607,000Source | -223,542,000Source | 186,739,000Source | 14,150,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 32,837,000Source | 75,090,000Source | — | 38,258,000Source | — | 59,436,000Source | — | 49,382,000Source | 272,924,000Source | 86,185,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 29,446,000Source | 27,487,000Source | 134,710,000Source | 141,547,000Source | 153,247,000Source | 107,022,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 20,042,000Source | 125,000Source | 12,471,000Source | 5,553,000Source | -6,283,000Source | 33,973,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -41,000Source | 542,000Source | 1,896,000Source | -901,000Source | 613,000Source | -3,485,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 5,680,000Source | — | — | — | — | — | — | 23,218,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | 29,000,000Source | 8,400,000Source | 29,000,000Source | 7,600,000Source | 29,000,000Source | 7,600,000Source | 74,000,000Source | 64,943,000Source | 83,500,000Source | 78,800,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 17,000,000Source | 16,100,000Source | 14,000,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | 183,000,000Source | 188,000,000Source | 136,000,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | 7,400,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | 55,509,000Source | 5,353,000Source | 27,274,000Source | 44,705,000Source | 34,882,000Source | 26,260,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | -1,101,000Source | 3,518,000Source | 0Source |
| GoodwillUSD | — | — | 1,228,140,000Source | 1,642,196,000Source | 1,228,140,000Source | 1,228,140,000Source | 1,228,140,000Source | 1,331,931,000Source | 1,228,140,000Source | 1,331,281,000Source | 1,638,846,000Source | 1,636,705,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 307,112,000Source | 0Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -5,607,000Source | 1,261,000Source | -89,070,000Source | -83,822,000Source | -6,468,000Source | -3,810,000Source | -102,682,000Source | — | — | 22,389,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -5,607,000Source | 1,261,000Source | -89,070,000Source | -83,822,000Source | -6,468,000Source | -3,810,000Source | -102,682,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -144,669,000Source | -14,031,000Source | — | -785,236,000Source | 0Source | -21,172,000Source | -997,960,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | -144,669,000Source | -14,031,000Source | — | -785,236,000Source | — | -21,172,000Source | -997,960,000Source | — | — | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 1,972,000Source | -303,000Source | 1,442,000Source | -1,127,000Source | -9,778,000Source | -1,588,000Source | 729,000Source | 5,329,000Source | -13,425,000Source | -11,498,000Source |
| InterestExpenseNonoperatingUSD | — | — | — | — | 34,539,000Source | 26,009,000Source | 32,348,000Source | 24,214,000Source | 107,183,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -150,276,000Source | -12,770,000Source | -89,070,000Source | -869,058,000Source | -6,468,000Source | -24,982,000Source | -1,100,642,000Source | -362,686,000Source | -41,301,000Source | 22,389,000Source |
| Nonoperating Income (Expense)USD | — | — | -1,076,000Source | -1,168,000Source | -643,000Source | -942,000Source | -1,023,000Source | -975,000Source | -3,942,000Source | -4,683,000Source | -4,837,000Source | -3,131,000Source |
| Operating Costs and ExpensesUSD | — | — | 670,794,000Source | 655,767,000Source | 648,384,000Source | 721,627,000Source | 610,655,000Source | 654,093,000Source | 2,734,572,000Source | — | — | — |
| Other Depreciation and AmortizationUSD | — | — | — | — | — | — | — | 1,201,000Source | — | 12,965,000Source | — | — |
| Other Operating Income (Expense), NetUSD | — | — | — | -15,727,000Source | — | — | — | -2,637,000Source | — | -13,316,000Source | -6,930,000Source | 5,252,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 42,602,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 697,264,000Source | 686,846,000Source | 613,234,000Source | 681,917,000Source | 627,780,000Source | 673,884,000Source | 2,762,032,000Source | 10,700,883,000Source | 10,333,967,000Source | 9,955,475,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 265,838,000Source | 272,322,000Source | 243,560,000Source | 267,853,000Source | 255,226,000Source | 262,370,000Source | 1,067,560,000Source | 1,909,791,000Source | 1,813,559,000Source | 1,633,668,000Source |
| Operating Income (Loss)USD | — | — | 26,470,000Source | 31,079,000Source | -35,150,000Source | -39,710,000Source | 17,125,000Source | 19,791,000Source | 27,460,000Source | -207,769,000Source | 104,508,000Source | 142,913,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -3,635,000Source | 958,000Source | -87,628,000Source | -84,949,000Source | -16,246,000Source | -5,398,000Source | -101,953,000Source | -357,357,000Source | -54,726,000Source | 10,891,000Source |
| Income Tax Expense (Benefit)USD | — | — | 1,972,000Source | -303,000Source | 1,442,000Source | -1,127,000Source | -9,778,000Source | -1,588,000Source | 729,000Source | 5,329,000Source | -13,425,000Source | -11,498,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -150,276,000Source | -12,770,000Source | -89,070,000Source | -869,058,000Source | -6,468,000Source | -24,982,000Source | -1,100,642,000Source | -362,686,000Source | -41,301,000Source | 22,389,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.94Source | -0.17Source | -1.16Source | -11.3Source | -0.08Source | -0.32Source | -14.31Source | -4.73Source | -0.54Source | 0.3Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.94Source | -0.16Source | -1.16Source | -11.3Source | -0.08Source | -0.32Source | -14.31Source | -4.73Source | -0.54Source | 0.29Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 77,288,000Source | 77,090,000Source | 76,695,000Source | 76,935,000Source | 76,432,000Source | 77,272,000Source | 76,897,000Source | 76,741,000Source | 75,785,000Source | 74,496,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 77,288,000Source | 78,476,000Source | 76,695,000Source | 76,935,000Source | 76,432,000Source | 77,272,000Source | 76,897,000Source | 76,741,000Source | 75,785,000Source | 76,217,000Source |
| Interest Expense (non-operating)USD | — | — | — | — | 34,539,000Source | 26,009,000Source | 32,348,000Source | 24,214,000Source | 107,183,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 29,000,000Source | 8,400,000Source | 29,000,000Source | 7,600,000Source | 29,000,000Source | 7,600,000Source | 74,000,000Source | 64,943,000Source | 83,500,000Source | 78,800,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | — | 6,500,000Source | 0Source | 6,400,000Source | 0Source | 16,000,000Source | 22,000,000Source | 22,000,000Source | 17,500,000Source | — |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 17,000,000Source | 16,100,000Source | 14,000,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | — | — | 337,649,000Source | 317,445,000Source | 311,511,000Source | 319,517,000Source | 315,392,000Source | 317,389,000Source | 1,323,336,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 18,616,000Source | 31,444,000Source | 10,308,000Source | 14,863,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 307,112,000Source | 0Source | — |
| Gross ProfitUSD | — | — | — | 559,706,000Source | — | — | — | 526,013,000Source | — | 2,219,155,000Source | 2,125,161,000Source | 1,826,351,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -5,607,000Source | 1,261,000Source | -89,070,000Source | -83,822,000Source | -6,468,000Source | -3,810,000Source | -102,682,000Source | — | — | 22,389,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -104,080,000Source | -383,475,000Source | -65,432,000Source | -17,650,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -5,607,000Source | 1,261,000Source | -89,070,000Source | -83,822,000Source | -6,468,000Source | -3,810,000Source | -102,682,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.07Source | 0.02Source | -1.16Source | -1.09Source | -0.08Source | -0.05Source | -1.34Source | -4.73Source | -0.54Source | 0.3Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.07Source | 0.02Source | -1.16Source | -1.09Source | -0.08Source | -0.05Source | -1.34Source | -4.73Source | -0.54Source | 0.29Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -144,669,000Source | -14,031,000Source | — | -785,236,000Source | 0Source | -21,172,000Source | -997,960,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | -144,669,000Source | -14,031,000Source | — | -785,236,000Source | — | -21,172,000Source | -997,960,000Source | — | — | 0Source |
| Interest ExpenseUSD | — | — | 29,029,000Source | 28,953,000Source | — | 26,009,000Source | — | 33,959,000Source | 107,183,000Source | 143,804,000Source | 157,915,000Source | 128,891,000Source |
| Nonoperating Income (Expense)USD | — | — | -1,076,000Source | -1,168,000Source | -643,000Source | -942,000Source | -1,023,000Source | -975,000Source | -3,942,000Source | -4,683,000Source | -4,837,000Source | -3,131,000Source |
| Operating Costs and ExpensesUSD | — | — | 670,794,000Source | 655,767,000Source | 648,384,000Source | 721,627,000Source | 610,655,000Source | 654,093,000Source | 2,734,572,000Source | — | — | — |
| Other Cost of Operating RevenueUSD | — | — | 5,724,000Source | 6,327,000Source | 5,321,000Source | 5,915,000Source | 5,471,000Source | 5,570,000Source | 22,567,000Source | — | — | — |
| Other Operating Income (Expense), NetUSD | — | — | — | -15,727,000Source | — | — | — | -2,637,000Source | — | -13,316,000Source | -6,930,000Source | 5,252,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | — | 13,000,000Source | 13,200,000Source | — |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-297475
Filing attachments
ach-ex99d1.htm · 8-K · 2026-11-18
Exhibit 99.1 Accendra Health Receives Delisting Notice From the New York Stock Exchange Trading Will Continue on the Over-the-Counter Market Under Ticker Symbol “ACCH” RICHMOND, Va., November 17, 2026 -- Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it received notification from the New York Stock Exchange (“NYSE”) on November 16, 2026, informing it that trading of the Company’s common stock on the NYSE was suspended, effective immediately, and that the NYSE has deter…
Read attachment ↗ach-ex99d1.htm · 8-K · 2026-11-05
Exhibit 99.1 Accendra Health Reports Third Quarter 2026 Financial Results RICHMOND, VA - November 5, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Over the several weeks since I started, a number of themes have become cl…
Read attachment ↗ach-ex99d2.htm · 8-K · 2026-11-05
Exhibit 99.2 Third Quarter 2026 Continuing Operations Supplemental Slides November 5, 2026 ──────────────────────────────────────────── p. 2 This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC’s Fair Disclosure Regulation. This presentation contains certain “forward looking” statements made pursuant to the Safe Harbor provisions of the Private Securities Litiga…
Read attachment ↗ach-ex99d1.htm · 8-K · 2026-11-02
Exhibit 99.1 Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029 Richmond, VA - November 2, 2026 - Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”) on October 29, 2026. The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged.…
Read attachment ↗ach-ex99d1.htm · 8-K · 2026-10-30
Exhibit 99.1 Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard RICHMOND, VA - October 30, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 27, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with Section 802…
Read attachment ↗ach-ex99d1.htm · 8-K · 2026-10-09
Exhibit 99.1 Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard RICHMOND, VA - October 9, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because, the average closing price o…
Read attachment ↗